The World Health Organization Expanded Programme of Research, Development and Research Training in Human Reproduction was established in 1972 to improve existing methods of fertility regulation, develop new methods and assist national authorities in devising the best ways of providing them on a continuing basis. Strengthening of national resources to carry out research in this field forms an important part of the programme. The programme is closely integrated with other W.H.O. research in human reproduction and in maternal and child health, and is closely linked with W.H.O.'s technical assistance programmes to governments. Research is being conducted by more than 650 scientists in 60 countries on a variety of methods that includes pills for women and men; injectables, again for both sexes; intra-uterine devices; vaginal rings; intracervical devices; rhythm methods; sterilization; termination of pregnancy; postcoital preparations; and birth control vaccines. The effectiveness, safety, acceptability and programme implications of these methods is being studied in populations of different constitutions and environments.
The Royal Society is a self-governing Fellowship of many of the world's most distinguished scientists drawn from all areas of science, engineering and medicine, and is the oldest scientific academy in continuous existence. The Society’s fundamental purpose, reflected in its founding Charters of the 1660s, is to recognise, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity. The Society has played a part in some of the most fundamental, significant, and life-changing discoveries in scientific history and Royal Society scientists continue to make outstanding contributions to science in many research areas.
This item is part of a JSTOR Collection.
For terms and use, please refer to our Terms and Conditions
Proceedings of the Royal Society of London. Series B, Biological Sciences
© 1976 Royal Society
Request Permissions
